Literature DB >> 17826732

Isoforms of alanine aminotransferases in human tissues and serum--differential tissue expression using novel antibodies.

Per Lindblom1, Ingalill Rafter, Clive Copley, Ulf Andersson, Jesper J Hedberg, Anna-Lena Berg, Anders Samuelsson, Heike Hellmold, Ian Cotgreave, Björn Glinghammar.   

Abstract

Serum alanine aminotransferase (ALT) is used as a clinical marker of hepatotoxicity. Two forms of ALT have been identified, ALT1 and ALT2, encoded by separate genes. The cellular and tissue distribution of the different ALT proteins has not been characterized in humans, and their relative contribution to serum is unknown. Here, we describe the development of novel isoenzyme specific ALT1 and ALT2 antibodies and the expression of the enzymes in human cells and organs. In normal human tissue, high expression of ALT1 was found in liver, skeletal muscle and kidney and low levels in heart muscle and not detectable in pancreas. High ALT2 reactivity was detected in heart and skeletal muscle, while no ALT2 expression was found in liver or kidney. Using immunohistochemistry, strong ALT1 reactivity was found in hepatocytes, renaltubular epithelial cells and in salivary gland epithelial cells, while ALT2 was expressed in adrenal gland cortex, neuronal cell bodies, cardiac myocytes, skeletal muscle fibers and endocrine pancreas. Immunoprecipitation using ALT antibodies on normal human serums showed ALT1 to be mainly responsible for basal ALT activity. Together, the results points to a differential expression of ALT1 and ALT2 in human organs and substantiate a need for investigations regarding the possible impacts on ALT measurements.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826732     DOI: 10.1016/j.abb.2007.07.023

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  23 in total

1.  Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features.

Authors:  Qing Ouyang; Tojo Nakayama; Ozan Baytas; Shawn M Davidson; Chendong Yang; Michael Schmidt; Sofia B Lizarraga; Sasmita Mishra; Malak Ei-Quessny; Saima Niaz; Mirrat Gul Butt; Syed Imran Murtaza; Afzal Javed; Haroon Rashid Chaudhry; Dylan J Vaughan; R Sean Hill; Jennifer N Partlow; Seung-Yun Yoo; Anh-Thu N Lam; Ramzi Nasir; Muna Al-Saffar; A James Barkovich; Matthew Schwede; Shailender Nagpal; Anna Rajab; Ralph J DeBerardinis; David E Housman; Ganeshwaran H Mochida; Eric M Morrow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

2.  Loss of function mutation in glutamic pyruvate transaminase 2 (GPT2) causes developmental encephalopathy.

Authors:  Katrina Celis; Scott Shuldiner; Eden V Haverfield; Joshua Cappell; Rongze Yang; Da-Wei Gong; Wendy K Chung
Journal:  J Inherit Metab Dis       Date:  2015-03-03       Impact factor: 4.982

Review 3.  Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

4.  Carbamoyl phosphate synthetase-1 is a rapid turnover biomarker in mouse and human acute liver injury.

Authors:  Sujith V W Weerasinghe; You-Jin Jang; Robert J Fontana; M Bishr Omary
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-06-12       Impact factor: 4.052

5.  Hepatic ALT isoenzymes are elevated in gluconeogenic conditions including diabetes and suppressed by insulin at the protein level.

Authors:  Kun Qian; Shao Zhong; Keming Xie; Daozhan Yu; Rongze Yang; Da-Wei Gong
Journal:  Diabetes Metab Res Rev       Date:  2015-06-17       Impact factor: 4.876

6.  Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects.

Authors:  Roberto Federico Villa; Antonella Gorini; Federica Ferrari
Journal:  Neurochem Res       Date:  2022-01-31       Impact factor: 3.996

7.  Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity.

Authors:  Rong-Ze Yang; Soohyun Park; William J Reagan; Rick Goldstein; Shao Zhong; Michael Lawton; Francis Rajamohan; Kun Qian; Li Liu; Da-Wei Gong
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

8.  Expression, purification, and initial characterization of human alanine aminotransferase (ALT) isoenzyme 1 and 2 in High-five insect cells.

Authors:  Li Liu; Shao Zhong; Rongze Yang; Hong Hu; Daozhan Yu; Dalong Zhu; Zichun Hua; Alan R Shuldiner; Richard Goldstein; William J Reagan; Da-Wei Gong
Journal:  Protein Expr Purif       Date:  2008-04-26       Impact factor: 1.650

9.  Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study.

Authors:  Sebastian J Reinstadler; Martin Reindl; Hans-Josef Feistritzer; Gert Klug; Agnes Mayr; Markus Kofler; Alexander Minh-Duc Tu; Luc Huybrechts; Johannes Mair; Wolfgang-Michael Franz; Bernhard Metzler
Journal:  Wien Klin Wochenschr       Date:  2015-10-06       Impact factor: 1.704

Review 10.  Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.